Abstract:ABSTRACT In a healthy colon, the stratified mucus layer serves as a crucial innate immune barrier to protect the epithelium from microbes. Mucins are complex glycoproteins that serve as a nutrient source for resident microflora and can be exploited by pathogens. We aimed to understand how the intestinal pathogen, Clostridioides difficile , independently uses or manipulates mucus to its benefit, without contributions from members of the microbiota. Using a 2-D primary human intestinal epithelial cell model to generate physiologic mucus, we assessed C. difficile- mucus interactions through growth assays, RNA-Seq, biophysical characterization of mucus, and contextualized metabolic modeling. We found that host-derived mucus promotes C. difficile growth both in vitro and in an infection model. RNA-Seq revealed significant upregulation of genes related to central metabolism in response to mucus, including genes involved in sugar uptake, the Wood-Ljungdahl pathway, and the glycine cleavage system. In addition, we identified differential expression of genes related to sensing and transcriptional control. Analysis of mutants with deletions in highly upregulated genes reflected the complexity of C. difficile -mucus interactions, with potential interplay between sensing and growth. Mucus also stimulated biofilm formation in vitro , which may in turn alter the viscoelastic properties of mucus. Context-specific metabolic modeling confirmed differential metabolism and the predicted importance of enzymes related to serine and glycine catabolism with mucus. Subsequent growth experiments supported these findings, indicating mucus is an important source of serine. Our results better define responses of C. difficile to human gastrointestinal mucus and highlight flexibility in metabolism that may influence pathogenesis. IMPORTANCE Clostridioides difficile results in upward of 250,000 infections and 12,000 deaths annually in the United States. Community-acquired infections continue to rise, and recurrent disease is common, emphasizing a vital need to understand C. difficile pathogenesis. C. difficile undoubtedly interacts with colonic mucus, but the extent to which the pathogen can independently respond to and take advantage of this niche has not been explored extensively. Moreover, the metabolic complexity of C. difficile remains poorly understood but likely impacts its capacity to grow and persist in the host. Here, we demonstrate that C. difficile uses native colonic mucus for growth, indicating C. difficile possesses mechanisms to exploit the mucosal niche. Furthermore, mucus induces metabolic shifts and biofilm formation in C. difficile , which has potential ramifications for intestinal colonization. Overall, our work is crucial to better understand the dynamics of C. difficile -mucus interactions in the context of the human gut.

Environmental and Nutritional Parameters Modulating Genetic Expression for Virulence Factors of Clostridioides difficile

Enterococci enhance Clostridioides difficile pathogenesis

Elucidating human gut microbiota interactions that robustly inhibit diverse Clostridioides difficile strains across different nutrient landscapes

Make It Less difficile: Understanding Genetic Evolution and Global Spread of Clostridioides difficile

Genomic surveillance of Clostridioides difficile transmission and virulence in a healthcare setting

Cyclic diguanylate differentially regulates the expression of virulence factors and pathogenesis-related phenotypes in Clostridioides difficile

Modulation of Lactobacillus Rhamnosus GG on the Gut Microbiota and Metabolism in Mice with Clostridioides Difficile Infection

Clostridioides difficile infection is associated with differences in transcriptionally active microbial communities

Pro-inflammatory Pathways Contribute to Pathogenesis of Clostridioides difficile Infection in a Murine Model - A Spatial Transcriptomics Study

Human gut microbiota interactions shape the long-term growth dynamics and evolutionary adaptations of Clostridioides difficile

Metabolism the Difficile Way: The Key to the Success of the Pathogen Clostridioides difficile

Engineering probiotics to inhibit Clostridioides difficile infection by dynamic regulation of intestinal metabolism

Microbial ecology between Clostridioides difficile and gut microbiota

Exploring the Toxin-Mediated Mechanisms in Clostridioides difficile Infection

Integrating gut microbiome and host immune markers to understand the pathogenesis of Clostridioides difficile infection

Predictive regulatory and metabolic network models for systems analysis of Clostridioides difficile

New Insights Into Functions and Possible Applications of Clostridium difficile CRISPR-Cas System

Understanding host immune responses in Clostridioides difficile infection: Implications for pathogenesis and immunotherapy

Clostridioides difficile-mucus interactions encompass shifts in gene expression, metabolism, and biofilm formation

Influence of microbiota on the growth and gene expression of Clostridioides difficile in an in vitro coculture model

Probiotics: insights and new opportunities for Clostridioides difficile intervention